FDA advisory panel voices concern over risks of HIV vaccine trials in teenagers

June 11, 2008

An FDA advisory panel on Monday voiced concern over the potential risks of conducting early HIV vaccine trials among teenagers in the U.S., Bloomberg reports. According to the panel, although such trials are justified in countries where HIV/AIDS is spreading more quickly, the risks might not outweigh the benefits in the U.S. (News-Medical)